Although the analyzed patients with CD4 <200/μl were on PCP prophylaxis, their clinical course was not influenced by ART, because the presenting study applied archive samples and data collected before ART was widely introduced in northern Thailand [21]. The gene discussed is CD4; the disease is pneumocystosis.